SUMMARY Among 1809 patients with myocardial infarction, 60 (3-3%) later developed a postmyocardial infarction syndrome. These 60 patients were compared with controls with myocardial infarction but without postmyocardial infarction syndrome. Cases with postmyocardial infarction syndrome had larger and more complicated infarcts than control subjects. Five year cumulative mortality was higher among cases (26%) than among control subjects (18%) but this difference was not statistically significant. Corticosteroid treatment did not adversely affect the prognosis of the postmyocardial infarction syndrome, which we conclude is mainly determined by the severity of the underlying coronary heart disease.
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The postmyocardial infarction syndrome was first described in 1955 by Dressler.' It is characterised by pleuropericardial pain, fever, and a high erythrocyte sedimentation rate occurring weeks or months after a myocardial infarction. The prevalence varies from 0 to 4*6% of cases with myocardial infarction in different studies. [2] [3] [4] [5] [6] [7] Dressler6 concluded that on the whole it was a benign but annoying complication. To the best of our knowledge, however, no studies have been published comparing the prognosis of patients with postmyocardial infarction syndrome with that of patients with myocardial infarction without it.
The purpose of the present study was to establish this in a non-selected large group of patients with myocardial infarction. 12 April 1983 to registration is hereafter called the index myocardial infarction. All cases were followed up until the end of 1978.
Before discharge from hospital and at the first appointment at the postmyocardial infarction clinic all patients were interviewed with respect to symptoms and case history. Using special forms to ensure the uniform collection of data9 information about hyper--tension, angina pectoris, and smoking habits before and after the myocardial infarction was collected. Findings during the hospital stay for the index myocardial infarction were also recorded on special forms. Left ventricular failure was considered to be present when more than occasional basal pulmonary riles and/or increased prominence of pulmonary vessels onx-ray film were recorded. Episodes of ventricular tachycardia or ventricular fibrillation were also recorded. Maximum enzyme levels were noted for serum aspartate aminotransferase (AST) which was determined once daily for a minimum of three days. Before discharge from hospital a chest x-ray film was done and the heart volume was calculated as described by Jonsell. 10 These factors have earlier been found to be of prognostic importance.11
Patients with the postmyocardial infarction syndrome were diagnosed from available data collected both during the hospital stay and at the postmyocardial infarction clinic. Criteria for a definite diagnosis of postmyocardial infarction syndrome were: (1) pleuropericardial pain, (2) fever (>37*50C), --and (3) a high erythrocyte sedimentation rate (>40 mm) if these developed more than a week after the Characteristics, prevalence, and prognosis ofpost-myocardial infarction syndrome myocardial infarction. If only two of these three symptoms and signs were present the patient was considered to have a probable postmyocardial infarction syndrome. In all cases other diseases capable of causing these symptoms and signs had to be excluded before the case was accepted. Thus, reinfarction, venous thrombosis, pulmonary embolism, heart failure, various infections such as bronchopneumonia and those of the urinary tract, and collagen and malignant diseases had to be ruled out.
During follow-up the patients were seen regularly at the postmyocardial infarction clinic, on average every sixth week during the first year of follow-up. Thereafter they were seen as often as was deemed necessary from a clinical standpoint but always at two and five years after the index myocardial infarction. Standardised criteria were used for institution of treatment, for instance digitalis and diuretics. The patients were attended by a small team of physicians and the methods were continuously checked to avoid intra-and interobserver variations.9
In order to establish the prognostic contribution of a diagnosis of postmyocardial infarction syndrome, two different matching procedures were applied. Matched controls were chosen consecutively from the files having their index myocardial infarction after the myocardial infarction of the case. In the first match two control subjects for each case with postmyocardial infarction syndrome were chosen, and the matching factors were age, sex, and the interval between the index myocardial infarction and the development of the postmyocardial infarction syndrome. Since the latter can only be diagnosed in life, often months after myocardial infarction, and since the mortality rate after infarction is highest during the first months, this interval must be used when matching control subjects or the data will be biased prognostically in favour of the patients with the post-myocardial infarction syndrome.
The second match was made for secondary risk factors, namely maximum enzyme rise (AST) and left ventricular failure during the index myocardial infarction (severity matched controls). These factors are an approximate estimate of infarct size. Age, sex, and the interval between the infarction and the occurrence of the postmyocardial infarction syndrome as in the first match were also included as matching criteria and again two control subjects were chosen for each case. This match was made in order to obtain a more precise estimate of the prognostic importance of the postmyocardial infarction syndrome. Thirty-four control subjects in the first match were also included in the second. Table 1 shows that both groups of control subjects were matched accurately with respect to age. Tables 1   and 2 show that the severity matched control subjects had similar AST maximum rise and the same frequency of left ventricular failure as those with the postmyocardial infarction syndrome. Patients who developed this within three months (65%) were matched with control subjects (65% in each group) who survived for three months. The other 35% of patients were matched to 35% in each control group who survived one year.
All 60 patients with postmyocardial infarction syndrome were compared with the two groups of matched control subjects. Table 3 shows certain characteristics before and after the index myocardial infarction. Patients with the postmyocardial infarction syndrome had had a myocardial infarction more often than either group of control subjects. There were no differences in the frequency of angina pectoris and hypertension before the index myocardial infarction and smoking habits before and after it were similar. Tables 1 and 2 show characteristics of prognostic 141 The follow-up for cases and age and sex matched control subjects ranged from one and a half to 11 years. Fourteen patients and 30 subjects of both control groups had been followed for less than five years.
Fourteen patients and 20 control subjects of the first group died within five years of follow-up. Fig. 1 illustrates the cumulative five year mortality, which was 26% among patients and 18%Yo among control subjects of the first match, a non-significant difference. Nonfatal reinfarctions during the same follow-up time were 23% in the cases and 22% in the control subjects. Steroid treated and non-steroid treated patients with the postmyocardial infarction syndrome had similar five year cumulative mortality rates (26% versus 23%). (By "cumulative mortality" we mean an actuarial calculation of the mortality of each year of followup separately on the basis only of the patients followed throughout that year or until earlier death. 12) The controls matched for severity had a five year cumulative mortality of 29% (Fig. 2) . This is again not significantly different from the mortality among patients with the postmyocardial infarction syndrome. In this group 32 control subjects had died within five years of follow-up. In summary, the prognosis of the postmyocardial infarction syndrome is influenced by the prognosis of the underlying myocardial infarction and not by the severity of the syndrome itself or by corticosteroid treatment. 
